Distribution of CCR5-∆32 and HLA-B*57:01alleles in HIV-seropositive and HIV-exposed seronegative Peruvian individuals
Preprint
- 5 May 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Little information is available about CCR5-Δ32 and HLA-B*57:01 alleles in the Peruvian population, especially in HIV-negative people with high-risk sexual behavior. In this study, we described the prevalence of these alleles in HIV-exposed seronegative individuals (PS) and HIV-seropositive individuals (PVV). For this purpose, 300 individuals were recruited: 150 from each group, and the selected alleles were characterized by endpoint PCR, real-time PCR, and DNA sequencing, respectively. According to our results, the prevalence of CCR5/CCR5-Δ32 heterozygous was 2.7%, and no homozygous cases were found. The population was in Hardy-Weinberg equilibrium for the CCR5 locus. Regarding HLA-B*57:01, only one case was found in the PS group, while no case was found from PVV group. No statistical difference was detected between both groups (p>0.05). In conclusion, we showed a low prevalence for CCR5-Δ32 as HLA-B*57:01 in Peruvian population. Since these alleles were also found indistinguishably from positives and negative Peruvian people with high-risk sexual behavior, it is possible that other genetic factor can play an important role to non-transmission of HIV in this population. Further cost-effectiveness studies are required to justify the genotyping test by using HLA-B*57:01 allele as routine test in Peru.Keywords
All Related Versions
- Version 1, 2025-05-05, Research Square
- Published version: Human Genome Variation, 12 (1), 1.
This publication has 23 references indexed in Scilit:
- Abacavir adverse reactions related with HLA-B*57:01 haplotype in a large cohort of patients infected with HIVPharmacogenetics and Genomics, 2020
- Evolutionary genomic dynamics of Peruvians before, during, and after the Inca EmpireProceedings of the National Academy of Sciences, 2018
- Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centersHuman Immunology, 2017
- Development of HLA-B*57:01 Genotyping Real-Time PCR with Optimized Hydrolysis Probe DesignThe Journal of Molecular Diagnostics, 2017
- Prevalence of HLA‐B*57:01 allele in Argentinean HIV‐1 infected patientsTissue Antigens, 2015
- HLA B*5701 status, disease progression, and response to antiretroviral therapyAIDS, 2013
- Host genes associated with HIV/AIDS: advances in gene discoveryTrends in Genetics, 2010
- HLA-B*5701 Screening for Hypersensitivity to AbacavirNew England Journal of Medicine, 2008
- Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Δ32 deletionJournal of Vascular Surgery, 2004
- Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavirThe Lancet, 2002